investigating relapse after allo-sct in aml
Published 5 years ago • 183 plays • Length 2:50Download video MP4
Download video MP3
Similar videos
-
1:13
prevention, detection and treatment of aml relapse after allo-sct
-
3:24
pre-induction azacitidine and venetoclax to improve the bone marrow microenvironment in aml
-
2:42
the use of targeted therapy to prevent relapse post-transplant
-
1:34
single-center study evaluating the outcomes of patients with aml who relapsed after allosct
-
2:43
magrolimab azacitidine in tp53-mutant aml
-
6:39
treatment failure and relapse in acute myeloid leukemia (aml)
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
2:06
preventing relapse post-transplant in aml and mds?
-
1:35
flt3 inhibitor maintenance after allo-sct for aml
-
2:34
improving outcomes for patients who relapse after allosct & evaluating cd19 cars against emd in all
-
1:56
incorporating novel agents for myelofibrosis in the pre- and post-transplant settings
-
2:38
managing relapse in aml: the role of mrd
-
2:02
relapse incidence post-allosct with ptcy for aml in cr1
-
4:15
using mrd to guide post-allosct treatment decisions in aml
-
1:13
the importance of cd47 as a target in mds and aml
-
3:41
mrd-guided therapy in patients with intermediate-risk aml compared to unguided cohort using psm
-
3:41
managing post-transplant relapse in aml
-
3:17
aml relapse after hsct: trends and predictive factors
-
2:48
outcomes of autosct, allosct & car-t cell therapy in patients with tp53-altered mcl